Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Capricor Therapeutics
Biotech
Capricor responds to cell therapy snub, disputes FDA’s concerns
Capricor called the rejection "difficult to understand" because the FDA had originally okayed the company's submission plan.
Darren Incorvaia
Sep 9, 2025 11:44am
FDA plans real-time release of drug rejection letters
Sep 4, 2025 1:45pm
FDA rejects Capricor’s DMD cell therapy, asks for more data
Jul 11, 2025 9:18am
BMS oncology head swings to Syndax—Chutes & Ladders
May 16, 2025 8:30am
Capricor shares turn red as FDA announces deramiocel adcomm plan
May 6, 2025 8:32am
Capricor shares more data for DMD therapy after initiating BLA
Oct 11, 2024 11:50am